Fig. 1 · Structure
Documents & Downloads
Amrinone
Phosphodiesterase III Inhibitor
Amrinone is a selective phosphodiesterase III inhibitor that enhances cardiac contractility and promotes vasodilation by increasing levels of cyclic adenosine monophosphate (cAMP). Its primary biological activity makes it a valuable agent in the treatment of heart failure and other cardiovascular disorders. Additionally, Amrinone can be utilized in research applications focused on cardiovascular physiology and pharmacology, given its non-glycosidic and non-catecholamine nature as a cardiotonic agent.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Inhibitor |
| CAS Number | 60719-84-8 |
| Applications | Phosphodiesterase III Inhibitor |
| Formula | C10H9N3O |
| Molecular Weight | 187.20 |
| Synonyms | Inamrinone |
| SMILES | O=C1C(N)=CC(C2=CC=NC=C2)=CN1 |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.